{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T11:44:31Z","timestamp":1707651871850},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,8]]},"DOI":"10.7759\/cureus.53884","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T07:35:41Z","timestamp":1707464141000},"source":"Crossref","is-referenced-by-count":0,"title":["The Clinicopathological Correlation of KRAS Mutation and PTEN Expression Status in Primary and Metastatic Colorectal Carcinoma"],"prefix":"10.7759","author":[{"given":"Redir T","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashar","family":"AL Hassawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysoon","family":"Alkazzaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093260","article-title":"Colorectal adenomas - genetics and searching for new molecular screening biomarkers","volume":"21","author":"Siskova A","year":"2020","unstructured":"Siskova A, Cervena K, Kral J, Hucl T, Vodicka P, Vymetalkova V. Colorectal adenomas - genetics and searching for new molecular screening biomarkers. Int J Mol Sci. 2020, 21:3260. 10.3390\/ijms21093260","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147217","article-title":"Detection of a tumor suppressor gene variant predisposing to colorectal cancer in an 18th century Hungarian mummy","volume":"11","author":"Feldman M","year":"2016","unstructured":"Feldman M, Hershkovitz I, Sklan EH, Kahila Bar-Gal G, Pap I, Szikossy I, Rosin-Arbesfeld R. Detection of a tumor suppressor gene variant predisposing to colorectal cancer in an 18th century Hungarian mummy. PLoS One. 2016, 11:e0147217. 10.1371\/journal.pone.0147217","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/srep29765","article-title":"Patterns of metastasis in colon and rectal cancer","volume":"6","author":"Riihim\u00e4ki M","year":"2016","unstructured":"Riihim\u00e4ki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016, 6:29765. 10.1038\/srep29765","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpsurg.2018.08.004","article-title":"Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?","volume":"55","author":"Stewart CL","year":"2018","unstructured":"Stewart CL, Warner S, Ito K, et al.. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?. Curr Probl Surg. 2018, 55:330-79. 10.1067\/j.cpsurg.2018.08.004","journal-title":"Curr Probl Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.03.002","article-title":"Targeting the untargetable KRAS in cancer therapy","volume":"9","author":"Liu P","year":"2019","unstructured":"Liu P, Wang Y, Li X. Targeting the untargetable KRAS in cancer therapy. Acta Pharm Sin B. 2019, 9:871-9. 10.1016\/j.apsb.2019.03.002","journal-title":"Acta Pharm Sin B"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-015-0075-0","article-title":"KRAS mutant lung cancer: progress thus far on an elusive therapeutic target","volume":"4","author":"Bhattacharya S","year":"2015","unstructured":"Bhattacharya S, Socinski MA, Burns TF. KRAS mutant lung cancer: progress thus far on an elusive therapeutic target. Clin Transl Med. 2015, 4:35. 10.1186\/s40169-015-0075-0","journal-title":"Clin Transl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050629","article-title":"The key roles of PTEN in T-cell acute lymphoblastic leukemia development, progression, and therapeutic response","volume":"11","author":"Martelli AM","year":"2019","unstructured":"Martelli AM, Paganelli F, Fazio A, Bazzichetto C, Conciatori F, McCubrey JA. The key roles of PTEN in T-cell acute lymphoblastic leukemia development, progression, and therapeutic response. Cancers (Basel). 2019, 11:629. 10.3390\/cancers11050629","journal-title":"Cancers (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.97","article-title":"PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival","volume":"2","author":"Atreya CE","year":"2013","unstructured":"Atreya CE, Sangale Z, Xu N, et al.. PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival. Cancer Med. 2013, 2:496-506. 10.1002\/cam4.97","journal-title":"Cancer Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00643","article-title":"EXOSC5 as a novel prognostic marker promotes proliferation of colorectal cancer via activating the ERK and AKT pathways","volume":"9","author":"Pan H","year":"2019","unstructured":"Pan H, Pan J, Song S, Ji L, Lv H, Yang Z. EXOSC5 as a novel prognostic marker promotes proliferation of colorectal cancer via activating the ERK and AKT pathways. Front Oncol. 2019, 9:643. 10.3389\/fonc.2019.00643","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.03.001","article-title":"Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations","volume":"54","author":"Holck S","year":"2016","unstructured":"Holck S, Bonde J, Pedersen H, Petersen AA, Chaube A, Nielsen HJ, Larsson LI. Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations. Hum Pathol. 2016, 54:37-46. 10.1016\/j.humpath.2016.03.001","journal-title":"Hum Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26741","article-title":"Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma","volume":"10","author":"Holck S","year":"2019","unstructured":"Holck S, Klarskov LL, Larsson LI. Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma. Oncotarget. 2019, 10:1745-55. 10.18632\/oncotarget.26741","journal-title":"Oncotarget"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2014.2032","article-title":"Involvement of the nuclear factor-\u03baB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-\u03b1","volume":"35","author":"Zhi Y","year":"2015","unstructured":"Zhi Y, Lu H, Duan Y, Sun W, Guan G, Dong Q, Yang C. Involvement of the nuclear factor-\u03baB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-\u03b1. Int J Mol Med. 2015, 35:349-57. 10.3892\/ijmm.2014.2032","journal-title":"Int J Mol Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8201","article-title":"Expression profile of NF-\u03baB regulated genes in sporadic colorectal cancer patients","volume":"15","author":"Gonz\u00e1lez-Quezada BA","year":"2018","unstructured":"Gonz\u00e1lez-Quezada BA, Santana-Bejarano UF, Corona-Rivera A, et al.. Expression profile of NF-\u03baB regulated genes in sporadic colorectal cancer patients. Oncol Lett. 2018, 15:7344-54. 10.3892\/ol.2018.8201","journal-title":"Oncol Lett"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li H","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010, 26:589-95. 10.1093\/bioinformatics\/btp698","journal-title":"Bioinformatics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera GA","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, et al.. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013, 43:11.10.1-11.10.33. 10.1002\/0471250953.bi1110s43","journal-title":"Curr Protoc Bioinformatics"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-016-0508-0","article-title":"In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity","volume":"11","author":"\u00c1goston EI","year":"2016","unstructured":"\u00c1goston EI, Micsik T, \u00c1cs B, et al.. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity. Diagn Pathol. 2016, 11:61. 10.1186\/s13000-016-0508-0","journal-title":"Diagn Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-3614","article-title":"PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer","volume":"19","author":"Day FL","year":"2013","unstructured":"Day FL, Jorissen RN, Lipton L, et al.. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer. Clin Cancer Res. 2013, 19:3285-96. 10.1158\/1078-0432.CCR-12-3614","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065821","article-title":"PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer","volume":"8","author":"Song M","year":"2013","unstructured":"Song M, Chen D, Lu B, et al.. PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer. PLoS One. 2013, 8:e65821. 10.1371\/journal.pone.0065821","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00024","article-title":"PTEN: multiple functions in human malignant tumors","volume":"5","author":"Milella M","year":"2015","unstructured":"Milella M, Falcone I, Conciatori F, et al.. PTEN: multiple functions in human malignant tumors. Front Oncol. 2015, 5:24. 10.3389\/fonc.2015.00024","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111765","article-title":"PTEN in colorectal cancer: shedding light on its role as predictor and target","volume":"11","author":"Salvatore L","year":"2019","unstructured":"Salvatore L, Calegari MA, Loupakis F, et al.. PTEN in colorectal cancer: shedding light on its role as predictor and target. Cancers (Basel). 2019, 11:1765. 10.3390\/cancers11111765","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13021","article-title":"AKT in cancer: new molecular insights and advances in drug development","volume":"82","author":"Mundi PS","year":"2016","unstructured":"Mundi PS, Sachdev J, McCourt C, Kalinsky K. AKT in cancer: new molecular insights and advances in drug development. Br J Clin Pharmacol. 2016, 82:943-56. 10.1111\/bcp.13021","journal-title":"Br J Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00965","article-title":"RAS: striking at the core of the oncogenic circuitry","volume":"9","author":"Gimple RC","year":"2019","unstructured":"Gimple RC, Wang X. RAS: striking at the core of the oncogenic circuitry. Front Oncol. 2019, 9:965. 10.3389\/fonc.2019.00965","journal-title":"Front Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.238865","article-title":"Pumping the brakes on RAS - negative regulators and death effectors of RAS","volume":"133","author":"Harrell Stewart DR","year":"2020","unstructured":"Harrell Stewart DR, Clark GJ. Pumping the brakes on RAS - negative regulators and death effectors of RAS. J Cell Sci. 2020, 133:jcs238865. 10.1242\/jcs.238865","journal-title":"J Cell Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/221693-the-clinicopathological-correlation-of-kras-mutation-and-pten-expression-status-in-primary-and-metastatic-colorectal-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:06Z","timestamp":1707506346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/221693-the-clinicopathological-correlation-of-kras-mutation-and-pten-expression-status-in-primary-and-metastatic-colorectal-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.53884","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}